Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis

Circulation

Volumn 94, Issue 5, 1996, Pages 922-927

  Nieto, F Javier ^a   Adam, Erwin ^b   Sorlie, Paul ^c   Farzadegan, Homayoon ^a   Melnick, Joseph L ^b   Comstock, George W ^a   Szklo, Moyses ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

atherosclerosis; carotid arteries; follow up studies; risk factors; viruses

Indexed keywords

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; B SCAN; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CYTOMEGALOVIRUS INFECTION; ENDARTERECTOMY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SMOOTH MUSCLE FIBER;

EID: 0029787360     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.5.922     Document Type: Article

References (41)

1. Frothingham C. The relation between acute infectious diseases and arterial lesions. Arch Intern Med. 1911;8:153-162.
2. Ophüls W. Arteriosclerosis and cardiovascular disease: their relation to infectious diseases. JAMA. 1921;76:700-701.
3. Fabricant CG, Fabricant J, Litrenta MM, Minick CR. Virus-induced atherosclerosis. J Exp Med. 1978;148:335-340.
4. Melnick JL, Petrie BL, Dreesman GR, McCollum CH, Petrie BL, Burek J, DeBakey ME. Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet. 1983;2644-647.
5. Petrie BL, Melnick JL, Adam E, Burek J, McCollum CH, DeBakey ME. Nucleic acid sequences of cytomegalovirus in cells cultured from human arterial tissue. J Infect Dis. 1987;155:158-159.
6. Hendrix MGR, Salimans MMM, van Boven CPA, Bruggeman CA. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol. 1990;136:23-28.
7. Melnick JL, Adam E, DeBakey ME. Cytomegalovirus and atherosclerosis. Eur Heart J. 1993;14(suppl K):30-38.
8. Melnick JL, Hu C, Burek J, Adam E, DeBakey ME. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J Med Virol. 1994;42:170-174.
9. Adam E, Melnick JL, Probtsfield JL, Petrie BL, Burek J, Bailey KR, McCollum CH, DeBakey ME. High level of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet. 1987;2:291-293.
10. Sorlie PD, Adam E, Melnick SL, Folsom A, Skelton T, Chambless LE, Barnes R, Melnick JL. Cytomegalovirus/herpes virus and carotid atherosclerosis: the ARIC Study. J Med Virol. 1994;42:33-37.
11. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74:1399-1406.
12. Comstock GW, Bush TL, Helzlsouer KJ, Hoffman SC. The Washington County Training Center: an exemplar of public health research in the field. Am J Epidemiol. 1991;134:1023-1029.
13. The ARIC Investigators. The Atherosclerosis Risk In Communities (ARIC) Study: design and objectives. Am J Epidemiol. 1989;129:687-702.
14. Comstock GW, Menkes MS, Schober SE, Vuilleumier J-P, Helsing KJ. Serum levels of retinol, beta-carotene, and alpha-toeopherol in older adults. Am J Epidemiol. 1988;127:114-123.
15. Riley WA, Barnes R, Bond MG, Evans GW, Chambless LE, Heiss G. High resolution B-mode ultrasound reading methods in the Atherosclerosis Risk in Communities Study (ARIC). J Neuroimaging. 1991;1:168-172.
16. Matson DO, Adler-Storthz K, Adam E, Dreesman GR. A micro solid-phase radioimmunoassay for detection of herpesvirus type-specific antibody: parameters involved in standardization. J Virol Methods. 1983;6:71-83.
17. Adler-Storthz K, Matson DO, Adam E, Dreesman GR. A micro solid-phase radioimmunoassay for detection of herpesvirus type-specific antibody: specificity and sensitivity. J Virol Methods. 1983;6:85-97.
18. Papp AC, Hatzakis H, Bracey A, Wu KK. ARIC hemostasis study-I: development of a blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost. 1989;61:15-19.
19. Wu KK, Papp AC, Patsch W, Rock R, Eckfeldt J, Sharrett AR. ARIC hemostasis study-II; organizational plan and feasibility study. Thromb Haemost. 1991;64:521-525.
20. Siedel J, Hägele EO, Ziegenhorn J, Wahlefeld AW. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem. 1983;29:1075-1080.
21. Heiss G, Sharrett AR, Barnes R, Chambless LE, Szklo M, Alzola C. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC Study. Am J Epidemiol. 1991;134:250-256.
22. Malinow MR, Nieto FJ, Szklo M, Chambless LE, Bond G. Carotid intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults: the Atherosclerosis Risk in Communities Study. Circulation. 1993;87:1107-1113.
23. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb. 1991;11:1245-1249.
24. Chambless LE, Barnes R, Folsom AR, Heiss G, Hutchinson R, Patsch W, Sharrett R, Szklo M, Wu K, Rosamond W. Carotid artery wall thickness is associated with incident coronary heart disease: early results of the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 1993;138:660. Abstract.
25. Bruggeman CA. Cytomegalovirus and latency: an overview. Virchows Arch B Cell Pathol. 1993;64:325-333.
26. Kirchner H. Immunobiology of infection with human cytomegalovirus. Adv Cancer Res. 1983;40:31-105.
27. Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, Epstein SE. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science. 1994;265:391-394.
28. Yamashiroya HM, Ghosh L, Yang R, Robertson AL. Herpesviridae in the coronary arteries and aorta of young trauma victims. Am J Pathol. 1988;130:71-79.
29. Hill AB. Observation and experiment. N Engl J Med. 1953;248:995-1001.
30. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA. 1989;261:3561-3566.
31. Melnick JL, Adam E, DeBakey ME. Possible role of cytomegalovirus in atherogenesis. JAMA. 1990;263:2204-2207.
32. Virus infections and atherosclerosis. Lancet. 1978;2:821-822. Editorial.
33. Fabricant CG, Krook L, Gillespie JH. Virus-induced cholesterol crystals. Science. 1973;181:566-567.
34. Hajjar DP, Grant AJ. Human herpesvirus induces altered cholesterol metabolism and accumulation in human arterial smooth muscle cells. Circulation. 1986;74(suppl II):II-26. Abstract.
35. Tumilowicz JJ, Gawlil ME, Powell BB, Trentin JJ. Replication of cytomegalovirus in human arterial smooth muscle cells. J Virol. 1985;56:839-845.
36. Benditt EP, Benditt JM. Evidence of a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci USA. 1973;70:1753-1756.
37. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
38. Span AHM, Van Boven CPA, Bruggeman CA. The effect of cytomegalovirus infection on the adherence of polymorphonuclear leukocytes to endothelial cells. Eur J Clin Invest. 1989;19:542-548.
39. Krech U. Complement-fixing antibodies against cytomegalovirus in different parts of the world. Bull World Health Org. 1973;49:103-106.
40. Fabricant CG, Fabricant J, Minick CR, Litrenta MM. Herpesvirusinduced atherosclerosis in chickens. Fed Proc. 1983;42:2476-2479.
41. Cunningham MJ, Pasternak RC. The potential role of viruses in the pathogenesis of atherosclerosis. Circulation. 1988;77:964-966.